Metraipolis › archive › dc_cded4ee29b35
Intratumoral heterogeneity as a potential biomarker for immunotherapy response and postoperative recurrence in NSCLC — Europe PMC PMID:42643285
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42643285
- DOI
- 10.3389/fimmu.2026.1852284
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T21:43:20.357Z
- SHA-256 of the archived text
aac6abc6bfc366431ec46d892186a44d007644f734f86224b940ee6438d56523- Stable URL of this page
https://metraipolis.com/documento/dc_cded4ee29b35
How to cite
Intratumoral heterogeneity as a potential biomarker for immunotherapy response and postoperative recurrence in NSCLC — Europe PMC PMID:42643285 — Europe PMC (en), https://europepmc.org/article/MED/42643285 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cded4ee29b35 (Metraipolis archive dc_cded4ee29b35, sha256 aac6abc6bfc366431ec46d892186a44d007644f734f86224b940ee6438d56523)
BibTeX
@misc{dccded4ee29b35,
title = {Intratumoral heterogeneity as a potential biomarker for immunotherapy response and postoperative recurrence in NSCLC — Europe PMC PMID:42643285},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42643285},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cded4ee29b35; sha256 aac6abc6bfc366431ec46d892186a44d007644f734f86224b940ee6438d56523},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42643285. Agents can read the archived copy with the MCP tool read_document.